Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 9.40245537 |
2 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 8.41264053 |
3 | regulation of chemokine secretion (GO:0090196) | 8.24982924 |
4 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.55571750 |
5 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.38520747 |
6 | macrophage activation involved in immune response (GO:0002281) | 6.15804456 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.79073739 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.79073739 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.79073739 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.79073739 |
11 | modulation by symbiont of host defense response (GO:0052031) | 5.79073739 |
12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.79073739 |
13 | chondroitin sulfate catabolic process (GO:0030207) | 5.67846778 |
14 | behavioral response to nicotine (GO:0035095) | 5.54758893 |
15 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 5.49214268 |
16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.41949484 |
17 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 5.27868417 |
18 | oligosaccharide catabolic process (GO:0009313) | 5.16580963 |
19 | ceramide catabolic process (GO:0046514) | 4.97018540 |
20 | macrophage activation (GO:0042116) | 4.95166570 |
21 | keratan sulfate catabolic process (GO:0042340) | 4.86296611 |
22 | nucleobase catabolic process (GO:0046113) | 4.84477333 |
23 | negative regulation of granulocyte differentiation (GO:0030853) | 4.76803204 |
24 | glycosphingolipid catabolic process (GO:0046479) | 4.76664689 |
25 | axonal fasciculation (GO:0007413) | 4.59198503 |
26 | neuron recognition (GO:0008038) | 4.49081864 |
27 | negative regulation of tissue remodeling (GO:0034104) | 4.41055097 |
28 | forebrain neuron differentiation (GO:0021879) | 4.34586708 |
29 | establishment of mitochondrion localization (GO:0051654) | 4.30234838 |
30 | presynaptic membrane organization (GO:0097090) | 4.29678289 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.29405043 |
32 | cyclooxygenase pathway (GO:0019371) | 4.20952280 |
33 | glycolipid catabolic process (GO:0019377) | 4.18542131 |
34 | purinergic receptor signaling pathway (GO:0035587) | 4.15185367 |
35 | postsynaptic membrane organization (GO:0001941) | 4.11798108 |
36 | regulation of cilium movement (GO:0003352) | 4.05345349 |
37 | negative regulation of norepinephrine secretion (GO:0010700) | 4.02927958 |
38 | negative regulation of axon guidance (GO:1902668) | 3.95779146 |
39 | adenosine receptor signaling pathway (GO:0001973) | 3.92066323 |
40 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.89951993 |
41 | neuronal ion channel clustering (GO:0045161) | 3.89049050 |
42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.88041062 |
43 | dendritic spine morphogenesis (GO:0060997) | 3.84375464 |
44 | regulation of extracellular matrix disassembly (GO:0010715) | 3.83133115 |
45 | retinal ganglion cell axon guidance (GO:0031290) | 3.80141090 |
46 | negative regulation of multicellular organism growth (GO:0040015) | 3.79324317 |
47 | head development (GO:0060322) | 3.79314792 |
48 | response to host (GO:0075136) | 3.78839984 |
49 | response to host defenses (GO:0052200) | 3.78839984 |
50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78839984 |
51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75857065 |
52 | transmission of nerve impulse (GO:0019226) | 3.75105438 |
53 | axon extension (GO:0048675) | 3.73728523 |
54 | monocyte differentiation (GO:0030224) | 3.72602172 |
55 | spinal cord development (GO:0021510) | 3.71162167 |
56 | outer ear morphogenesis (GO:0042473) | 3.70538068 |
57 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.70029357 |
58 | desmosome organization (GO:0002934) | 3.69182078 |
59 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.66670920 |
60 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.65703625 |
61 | hyaluronan catabolic process (GO:0030214) | 3.65626104 |
62 | regulation of microtubule-based movement (GO:0060632) | 3.64444446 |
63 | cell proliferation in forebrain (GO:0021846) | 3.64005382 |
64 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.63335144 |
65 | positive regulation of gastrulation (GO:2000543) | 3.59922965 |
66 | response to cholesterol (GO:0070723) | 3.59558772 |
67 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.59132829 |
68 | cell migration in hindbrain (GO:0021535) | 3.58158043 |
69 | presynaptic membrane assembly (GO:0097105) | 3.57677695 |
70 | protein polyglutamylation (GO:0018095) | 3.52476615 |
71 | phagocytosis, engulfment (GO:0006911) | 3.50138517 |
72 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.49549165 |
73 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.49549165 |
74 | negative regulation of stress fiber assembly (GO:0051497) | 3.49513204 |
75 | synapse assembly (GO:0007416) | 3.48418804 |
76 | olfactory bulb development (GO:0021772) | 3.48381875 |
77 | synaptic transmission, cholinergic (GO:0007271) | 3.47527054 |
78 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.47328556 |
79 | response to host immune response (GO:0052572) | 3.47328556 |
80 | mitochondrion transport along microtubule (GO:0047497) | 3.47218157 |
81 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.47218157 |
82 | macrophage differentiation (GO:0030225) | 3.46852447 |
83 | axon extension involved in axon guidance (GO:0048846) | 3.44534623 |
84 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.44534623 |
85 | positive regulation of interferon-alpha production (GO:0032727) | 3.44208158 |
86 | regulation of synapse structural plasticity (GO:0051823) | 3.43852007 |
87 | adaptation of signaling pathway (GO:0023058) | 3.36775345 |
88 | positive regulation of B cell differentiation (GO:0045579) | 3.35454577 |
89 | I-kappaB phosphorylation (GO:0007252) | 3.34501084 |
90 | nonmotile primary cilium assembly (GO:0035058) | 3.32827986 |
91 | neuron cell-cell adhesion (GO:0007158) | 3.30719286 |
92 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.29296081 |
93 | sphingolipid catabolic process (GO:0030149) | 3.29265107 |
94 | ruffle organization (GO:0031529) | 3.28849240 |
95 | tachykinin receptor signaling pathway (GO:0007217) | 3.28832363 |
96 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.28168459 |
97 | extracellular fibril organization (GO:0043206) | 3.27283062 |
98 | daunorubicin metabolic process (GO:0044597) | 3.24049833 |
99 | polyketide metabolic process (GO:0030638) | 3.24049833 |
100 | doxorubicin metabolic process (GO:0044598) | 3.24049833 |
101 | regulation of interferon-alpha production (GO:0032647) | 3.23040387 |
102 | spinal cord association neuron differentiation (GO:0021527) | 3.20524060 |
103 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.19640036 |
104 | protein localization to synapse (GO:0035418) | 3.19251756 |
105 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.15718812 |
106 | positive regulation of chemokine production (GO:0032722) | 3.15194881 |
107 | ganglion development (GO:0061548) | 3.12593268 |
108 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.12569365 |
109 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.10672840 |
110 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.09624272 |
111 | negative regulation of axon extension (GO:0030517) | 3.08439035 |
112 | response to sterol (GO:0036314) | 3.08106027 |
113 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.07747561 |
114 | regulation of axon guidance (GO:1902667) | 3.07726696 |
115 | ganglioside metabolic process (GO:0001573) | 3.05605835 |
116 | brain morphogenesis (GO:0048854) | 3.03293952 |
117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.03064383 |
118 | parturition (GO:0007567) | 3.02213077 |
119 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.02001768 |
120 | response to muramyl dipeptide (GO:0032495) | 3.01760148 |
121 | regulation of antigen processing and presentation (GO:0002577) | 3.01519675 |
122 | myeloid cell activation involved in immune response (GO:0002275) | 3.00426339 |
123 | regulation of collateral sprouting (GO:0048670) | 2.98419366 |
124 | auditory behavior (GO:0031223) | 2.97943364 |
125 | lysosome organization (GO:0007040) | 2.97015197 |
126 | lytic vacuole organization (GO:0080171) | 2.97015197 |
127 | negative regulation of bone resorption (GO:0045779) | 2.96924451 |
128 | hippocampus development (GO:0021766) | 2.96638453 |
129 | sodium-independent organic anion transport (GO:0043252) | 2.95382734 |
130 | macrophage chemotaxis (GO:0048246) | 2.94784718 |
131 | central nervous system myelination (GO:0022010) | 2.94600446 |
132 | axon ensheathment in central nervous system (GO:0032291) | 2.94600446 |
133 | adult walking behavior (GO:0007628) | 2.94586472 |
134 | neuron projection extension (GO:1990138) | 2.94347446 |
135 | negative regulation of interleukin-6 production (GO:0032715) | 2.94044304 |
136 | negative regulation of axonogenesis (GO:0050771) | 2.92780187 |
137 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.92490077 |
138 | positive regulation of synapse assembly (GO:0051965) | 2.92354674 |
139 | dendrite morphogenesis (GO:0048813) | 2.91537906 |
140 | membrane lipid catabolic process (GO:0046466) | 2.91098609 |
141 | gland morphogenesis (GO:0022612) | 2.88246788 |
142 | nucleoside diphosphate catabolic process (GO:0009134) | 2.86809343 |
143 | negative regulation of mast cell activation (GO:0033004) | 2.86780894 |
144 | cellular extravasation (GO:0045123) | 2.86013310 |
145 | short-term memory (GO:0007614) | 2.84795544 |
146 | response to peptidoglycan (GO:0032494) | 2.84567851 |
147 | cellular response to interferon-beta (GO:0035458) | 2.84418637 |
148 | limb bud formation (GO:0060174) | 2.84375314 |
149 | negative regulation of response to food (GO:0032096) | 2.82609315 |
150 | negative regulation of appetite (GO:0032099) | 2.82609315 |
151 | germ cell migration (GO:0008354) | 2.82305789 |
152 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.82140034 |
153 | pharyngeal system development (GO:0060037) | 2.81730042 |
154 | microtubule severing (GO:0051013) | 2.81544638 |
155 | gamma-aminobutyric acid transport (GO:0015812) | 2.80647491 |
156 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.79635737 |
157 | neurofilament cytoskeleton organization (GO:0060052) | 2.79065642 |
158 | regulation of monocyte differentiation (GO:0045655) | 2.78794409 |
159 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.78357760 |
160 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.77059580 |
161 | cell-cell junction maintenance (GO:0045217) | 2.76944994 |
162 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75299858 |
163 | positive regulation of mitochondrial fission (GO:0090141) | 2.74031744 |
164 | negative regulation of bone remodeling (GO:0046851) | 2.73902272 |
165 | fibril organization (GO:0097435) | 2.72458000 |
166 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.70545369 |
167 | Rac protein signal transduction (GO:0016601) | 2.68645563 |
168 | L-serine transport (GO:0015825) | 2.67071594 |
169 | negative regulation of osteoclast differentiation (GO:0045671) | 2.65613782 |
170 | cell junction maintenance (GO:0034331) | 2.64815727 |
171 | regulation of extent of cell growth (GO:0061387) | 2.64421140 |
172 | cornea development in camera-type eye (GO:0061303) | 2.63419565 |
173 | epithelial cilium movement (GO:0003351) | 2.61999337 |
174 | negative regulation of smooth muscle contraction (GO:0045986) | 2.61638432 |
175 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.61341739 |
176 | protein insertion into membrane (GO:0051205) | 2.60830947 |
177 | mechanosensory behavior (GO:0007638) | 2.59014005 |
178 | synaptic vesicle maturation (GO:0016188) | 2.58791600 |
179 | protein localization to cilium (GO:0061512) | 2.58715653 |
180 | regulation of axon extension (GO:0030516) | 2.58438220 |
181 | vocalization behavior (GO:0071625) | 2.58193082 |
182 | respiratory burst (GO:0045730) | 2.57977245 |
183 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.57518659 |
184 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.56869112 |
185 | neural tube formation (GO:0001841) | 2.56621634 |
186 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.56304941 |
187 | nervous system development (GO:0007399) | 2.56105684 |
188 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.55650638 |
189 | negative regulation of interleukin-2 production (GO:0032703) | 2.55536917 |
190 | regulation of feeding behavior (GO:0060259) | 2.52937563 |
191 | response to auditory stimulus (GO:0010996) | 2.51296561 |
192 | regulation of membrane repolarization (GO:0060306) | 2.51166040 |
193 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51157269 |
194 | synapse organization (GO:0050808) | 2.51083734 |
195 | neuron migration (GO:0001764) | 2.50577957 |
196 | somite development (GO:0061053) | 2.49412170 |
197 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.45577967 |
198 | positive regulation of chemokine secretion (GO:0090197) | 10.6169291 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.79612991 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.03500372 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.23628184 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.00139556 |
5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.96913357 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62845340 |
7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.38996186 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.31208953 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29279870 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.02017787 |
11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.89232051 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.75662209 |
13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.69062007 |
14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.61883706 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.58964319 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57893250 |
17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53822694 |
18 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.51785240 |
19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48922427 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35134599 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.34337355 |
22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30675563 |
23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.28075377 |
24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.27582445 |
25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26909370 |
26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25900459 |
27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22682802 |
28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.20827292 |
29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17045276 |
30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15550868 |
31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15049233 |
32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.11859439 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02565994 |
34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.02374241 |
35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.99561584 |
36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.98841459 |
37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.98841459 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.97919670 |
39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96292276 |
40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.93807514 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92401892 |
42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91472743 |
43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.85433262 |
44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83687042 |
45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83283712 |
46 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82555902 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81638897 |
48 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.76605867 |
49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.76217562 |
50 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.73723276 |
51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.70758184 |
52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.69176816 |
53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.68450547 |
54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65903434 |
55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.65717490 |
56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64470915 |
57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.61981612 |
58 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.59630475 |
59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.57861967 |
60 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.56034224 |
61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54795201 |
62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54181153 |
63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.53969736 |
64 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.48082276 |
65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47564469 |
66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.46983213 |
67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46983213 |
68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44949176 |
69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.44684853 |
70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43639745 |
71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41482339 |
72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39701266 |
73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38389564 |
74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37142004 |
75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36773353 |
76 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36725883 |
77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36417955 |
78 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35788324 |
79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35244406 |
80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34923032 |
81 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.32574024 |
82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31148365 |
83 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.26887094 |
84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26548597 |
85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24154680 |
86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24035680 |
87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23708189 |
88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23389161 |
89 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22929259 |
90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22064939 |
91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21949833 |
92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20118968 |
93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.19915587 |
94 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17625407 |
95 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17115550 |
96 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14825362 |
97 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11466897 |
98 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11047913 |
99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11047857 |
100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07485969 |
101 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06873637 |
102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06836763 |
103 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06503287 |
104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06402993 |
105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06233909 |
106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05713654 |
107 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.05587326 |
108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05318788 |
109 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04815910 |
110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04631548 |
111 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.04151808 |
112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03594991 |
113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03239936 |
114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02967967 |
115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02232383 |
116 | MYB_26560356_Chip-Seq_TH2_Human | 1.02077617 |
117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01268310 |
118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01150922 |
119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99442793 |
120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99325039 |
121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98730259 |
122 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98358425 |
123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96558786 |
124 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96489372 |
125 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.96268771 |
126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95812478 |
127 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95455202 |
128 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.94990606 |
129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94829031 |
130 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94555822 |
131 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94332075 |
132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94173320 |
133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93939793 |
134 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92742695 |
135 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92474791 |
136 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92474791 |
137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.92419041 |
138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91889886 |
139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91637133 |
140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91557508 |
141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91024847 |
142 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90861951 |
143 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90517621 |
144 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90443383 |
145 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90392770 |
146 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90123031 |
147 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89280563 |
148 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88757466 |
149 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88632649 |
150 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88532242 |
151 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88508401 |
152 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88472207 |
153 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88098471 |
154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87145802 |
155 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85629367 |
156 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85427780 |
157 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.84420911 |
158 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.84292855 |
159 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84175178 |
160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83767642 |
161 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83657790 |
162 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.83469365 |
163 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83359343 |
164 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.83307224 |
165 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83289075 |
166 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83258314 |
167 | MYC_22102868_ChIP-Seq_BL_Human | 0.81599230 |
168 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81520752 |
169 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81266098 |
170 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81138276 |
171 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80757401 |
172 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80299468 |
173 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77919390 |
174 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77911546 |
175 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75391597 |
176 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.75074846 |
177 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74820153 |
178 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.74473868 |
179 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74236088 |
180 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72500090 |
181 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.71963497 |
182 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.71622934 |
183 | P300_19829295_ChIP-Seq_ESCs_Human | 0.71449649 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003191_abnormal_cellular_cholesterol | 3.91206696 |
2 | MP0005058_abnormal_lysosome_morphology | 3.80385463 |
3 | MP0006082_CNS_inflammation | 3.63813422 |
4 | MP0005423_abnormal_somatic_nervous | 3.53772752 |
5 | MP0003787_abnormal_imprinting | 3.42103551 |
6 | MP0002254_reproductive_system_inflammat | 3.28924614 |
7 | MP0000778_abnormal_nervous_system | 3.20270098 |
8 | MP0003172_abnormal_lysosome_physiology | 3.14327273 |
9 | MP0003183_abnormal_peptide_metabolism | 3.06273578 |
10 | MP0003122_maternal_imprinting | 2.93572253 |
11 | MP0003880_abnormal_central_pattern | 2.90778432 |
12 | MP0009384_cardiac_valve_regurgitation | 2.88997635 |
13 | MP0003075_altered_response_to | 2.88319586 |
14 | MP0005671_abnormal_response_to | 2.84559747 |
15 | MP0008004_abnormal_stomach_pH | 2.71137744 |
16 | MP0002653_abnormal_ependyma_morphology | 2.66146548 |
17 | MP0005464_abnormal_platelet_physiology | 2.64644874 |
18 | MP0001984_abnormal_olfaction | 2.51819851 |
19 | MP0005275_abnormal_skin_tensile | 2.48439292 |
20 | MP0006276_abnormal_autonomic_nervous | 2.44646720 |
21 | MP0003121_genomic_imprinting | 2.39955063 |
22 | MP0001835_abnormal_antigen_presentation | 2.36326011 |
23 | MP0003690_abnormal_glial_cell | 2.35678101 |
24 | MP0005394_taste/olfaction_phenotype | 2.35578249 |
25 | MP0005499_abnormal_olfactory_system | 2.35578249 |
26 | MP0008789_abnormal_olfactory_epithelium | 2.28514948 |
27 | MP0008007_abnormal_cellular_replicative | 2.25779942 |
28 | MP0002419_abnormal_innate_immunity | 2.24621318 |
29 | MP0003279_aneurysm | 2.24205898 |
30 | MP0000465_gastrointestinal_hemorrhage | 2.22730344 |
31 | MP0000566_synostosis | 2.15516904 |
32 | MP0004859_abnormal_synaptic_plasticity | 2.02084874 |
33 | MP0003123_paternal_imprinting | 1.99855353 |
34 | MP0002396_abnormal_hematopoietic_system | 1.96652200 |
35 | MP0003635_abnormal_synaptic_transmissio | 1.95084853 |
36 | MP0004133_heterotaxia | 1.93080920 |
37 | MP0002102_abnormal_ear_morphology | 1.92693832 |
38 | MP0001851_eye_inflammation | 1.84270161 |
39 | MP0002184_abnormal_innervation | 1.83996959 |
40 | MP0003941_abnormal_skin_development | 1.82404531 |
41 | MP0000955_abnormal_spinal_cord | 1.81855785 |
42 | MP0005551_abnormal_eye_electrophysiolog | 1.80505952 |
43 | MP0002063_abnormal_learning/memory/cond | 1.79466137 |
44 | MP0003566_abnormal_cell_adhesion | 1.78579348 |
45 | MP0005166_decreased_susceptibility_to | 1.78193130 |
46 | MP0002557_abnormal_social/conspecific_i | 1.77580960 |
47 | MP0000383_abnormal_hair_follicle | 1.71454434 |
48 | MP0002452_abnormal_antigen_presenting | 1.71078693 |
49 | MP0001533_abnormal_skeleton_physiology | 1.69724921 |
50 | MP0002272_abnormal_nervous_system | 1.69670240 |
51 | MP0002148_abnormal_hypersensitivity_rea | 1.67865817 |
52 | MP0001970_abnormal_pain_threshold | 1.65862748 |
53 | MP0008438_abnormal_cutaneous_collagen | 1.64597264 |
54 | MP0002882_abnormal_neuron_morphology | 1.61433960 |
55 | MP0002166_altered_tumor_susceptibility | 1.60000721 |
56 | MP0002572_abnormal_emotion/affect_behav | 1.58756477 |
57 | MP0002009_preneoplasia | 1.58598425 |
58 | MP0009745_abnormal_behavioral_response | 1.58538639 |
59 | MP0002822_catalepsy | 1.55921447 |
60 | MP0001188_hyperpigmentation | 1.54184564 |
61 | MP0003890_abnormal_embryonic-extraembry | 1.53704355 |
62 | MP0002796_impaired_skin_barrier | 1.53600034 |
63 | MP0002752_abnormal_somatic_nervous | 1.53076752 |
64 | MP0004142_abnormal_muscle_tone | 1.52988856 |
65 | MP0005171_absent_coat_pigmentation | 1.51035029 |
66 | MP0002734_abnormal_mechanical_nocicepti | 1.50350913 |
67 | MP0004270_analgesia | 1.49962499 |
68 | MP0002090_abnormal_vision | 1.48796067 |
69 | MP0002064_seizures | 1.48776065 |
70 | MP0004885_abnormal_endolymph | 1.47820973 |
71 | MP0004883_abnormal_blood_vessel | 1.47121300 |
72 | MP0003436_decreased_susceptibility_to | 1.46990034 |
73 | MP0002060_abnormal_skin_morphology | 1.46457986 |
74 | MP0002733_abnormal_thermal_nociception | 1.45719447 |
75 | MP0003646_muscle_fatigue | 1.45651790 |
76 | MP0010386_abnormal_urinary_bladder | 1.45410135 |
77 | MP0002837_dystrophic_cardiac_calcinosis | 1.45253563 |
78 | MP0002998_abnormal_bone_remodeling | 1.44514766 |
79 | MP0001819_abnormal_immune_cell | 1.41815735 |
80 | MP0001485_abnormal_pinna_reflex | 1.41675052 |
81 | MP0001542_abnormal_bone_strength | 1.40591269 |
82 | MP0005645_abnormal_hypothalamus_physiol | 1.40319048 |
83 | MP0004811_abnormal_neuron_physiology | 1.39673553 |
84 | MP0002420_abnormal_adaptive_immunity | 1.39180605 |
85 | MP0003011_delayed_dark_adaptation | 1.38644021 |
86 | MP0001529_abnormal_vocalization | 1.35179494 |
87 | MP0002723_abnormal_immune_serum | 1.33870767 |
88 | MP0005000_abnormal_immune_tolerance | 1.31315108 |
89 | MP0001800_abnormal_humoral_immune | 1.31094515 |
90 | MP0002638_abnormal_pupillary_reflex | 1.30689619 |
91 | MP0000026_abnormal_inner_ear | 1.30563312 |
92 | MP0004742_abnormal_vestibular_system | 1.29264393 |
93 | MP0001486_abnormal_startle_reflex | 1.28868659 |
94 | MP0005390_skeleton_phenotype | 1.28459926 |
95 | MP0001968_abnormal_touch/_nociception | 1.27540775 |
96 | MP0001440_abnormal_grooming_behavior | 1.27435669 |
97 | MP0003136_yellow_coat_color | 1.24436936 |
98 | MP0005195_abnormal_posterior_eye | 1.23762375 |
99 | MP0000631_abnormal_neuroendocrine_gland | 1.23514452 |
100 | MP0009046_muscle_twitch | 1.23440527 |
101 | MP0010678_abnormal_skin_adnexa | 1.23022554 |
102 | MP0002152_abnormal_brain_morphology | 1.22435747 |
103 | MP0002933_joint_inflammation | 1.21196640 |
104 | MP0003303_peritoneal_inflammation | 1.21158681 |
105 | MP0002067_abnormal_sensory_capabilities | 1.19496169 |
106 | MP0001853_heart_inflammation | 1.19487414 |
107 | MP0005508_abnormal_skeleton_morphology | 1.19404945 |
108 | MP0004145_abnormal_muscle_electrophysio | 1.18173726 |
109 | MP0002751_abnormal_autonomic_nervous | 1.15533488 |
110 | MP0005023_abnormal_wound_healing | 1.14745963 |
111 | MP0003938_abnormal_ear_development | 1.12795599 |
112 | MP0002735_abnormal_chemical_nociception | 1.12725124 |
113 | MP0005646_abnormal_pituitary_gland | 1.11935870 |
114 | MP0008877_abnormal_DNA_methylation | 1.11917260 |
115 | MP0001915_intracranial_hemorrhage | 1.11735277 |
116 | MP0000343_altered_response_to | 1.10532225 |
117 | MP0001216_abnormal_epidermal_layer | 1.09415259 |
118 | MP0003300_gastrointestinal_ulcer | 1.05262754 |
119 | MP0008995_early_reproductive_senescence | 1.04880067 |
120 | MP0002928_abnormal_bile_duct | 1.04687704 |
121 | MP0003724_increased_susceptibility_to | 1.03924807 |
122 | MP0005253_abnormal_eye_physiology | 1.03552025 |
123 | MP0001905_abnormal_dopamine_level | 1.03550906 |
124 | MP0006292_abnormal_olfactory_placode | 1.01901278 |
125 | MP0000858_altered_metastatic_potential | 1.01534352 |
126 | MP0002229_neurodegeneration | 1.00387624 |
127 | MP0003861_abnormal_nervous_system | 1.00219079 |
128 | MP0003329_amyloid_beta_deposits | 0.98913085 |
129 | MP0005025_abnormal_response_to | 0.98706226 |
130 | MP0000716_abnormal_immune_system | 0.97381363 |
131 | MP0002163_abnormal_gland_morphology | 0.95587784 |
132 | MP0005670_abnormal_white_adipose | 0.95300174 |
133 | MP0003633_abnormal_nervous_system | 0.95268924 |
134 | MP0003453_abnormal_keratinocyte_physiol | 0.94491509 |
135 | MP0003045_fibrosis | 0.91437760 |
136 | MP0002398_abnormal_bone_marrow | 0.90993106 |
137 | MP0000049_abnormal_middle_ear | 0.90872663 |
138 | MP0001963_abnormal_hearing_physiology | 0.90701223 |
139 | MP0001324_abnormal_eye_pigmentation | 0.90654385 |
140 | MP0005084_abnormal_gallbladder_morpholo | 0.90132522 |
141 | MP0003879_abnormal_hair_cell | 0.89324918 |
142 | MP0008469_abnormal_protein_level | 0.87648665 |
143 | MP0002095_abnormal_skin_pigmentation | 0.87596080 |
144 | MP0000604_amyloidosis | 0.87420456 |
145 | MP0002066_abnormal_motor_capabilities/c | 0.87323059 |
146 | MP0000538_abnormal_urinary_bladder | 0.87281716 |
147 | MP0003942_abnormal_urinary_system | 0.87133099 |
148 | MP0010771_integument_phenotype | 0.87045849 |
149 | MP0006072_abnormal_retinal_apoptosis | 0.86896237 |
150 | MP0001845_abnormal_inflammatory_respons | 0.86569642 |
151 | MP0001346_abnormal_lacrimal_gland | 0.86400224 |
152 | MP0000689_abnormal_spleen_morphology | 0.85559384 |
153 | MP0002098_abnormal_vibrissa_morphology | 0.85394437 |
154 | MP0003763_abnormal_thymus_physiology | 0.85366886 |
155 | MP0001502_abnormal_circadian_rhythm | 0.84851317 |
156 | MP0000647_abnormal_sebaceous_gland | 0.84764336 |
157 | MP0001986_abnormal_taste_sensitivity | 0.84350154 |
158 | MP0005165_increased_susceptibility_to | 0.83690326 |
159 | MP0009764_decreased_sensitivity_to | 0.83112692 |
160 | MP0002006_tumorigenesis | 0.82723366 |
161 | MP0002736_abnormal_nociception_after | 0.82498119 |
162 | MP0003795_abnormal_bone_structure | 0.82334565 |
163 | MP0002909_abnormal_adrenal_gland | 0.81916271 |
164 | MP0002722_abnormal_immune_system | 0.80453045 |
165 | MP0002429_abnormal_blood_cell | 0.76929415 |
166 | MP0003385_abnormal_body_wall | 0.76402529 |
167 | MP0000767_abnormal_smooth_muscle | 0.76350783 |
168 | MP0008569_lethality_at_weaning | 0.75236772 |
169 | MP0004947_skin_inflammation | 0.74752273 |
170 | MP0003755_abnormal_palate_morphology | 0.74346732 |
171 | MP0005391_vision/eye_phenotype | 0.74292896 |
172 | MP0005647_abnormal_sex_gland | 0.73933334 |
173 | MP0009333_abnormal_splenocyte_physiolog | 0.72652883 |
174 | MP0000427_abnormal_hair_cycle | 0.72599186 |
175 | MP0002277_abnormal_respiratory_mucosa | 0.72125722 |
176 | MP0005197_abnormal_uvea_morphology | 0.71865092 |
177 | MP0001293_anophthalmia | 0.71574410 |
178 | MP0005386_behavior/neurological_phenoty | 0.71030820 |
179 | MP0004924_abnormal_behavior | 0.71030820 |
180 | MP0003634_abnormal_glial_cell | 0.70914724 |
181 | MP0001545_abnormal_hematopoietic_system | 0.70825045 |
182 | MP0005397_hematopoietic_system_phenotyp | 0.70825045 |
183 | MP0004858_abnormal_nervous_system | 0.70023577 |
184 | MP0005164_abnormal_response_to | 0.69500800 |
185 | MP0001790_abnormal_immune_system | 0.69205455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 8.14566474 |
2 | Glomerulonephritis (HP:0000099) | 6.44200981 |
3 | Arterial tortuosity (HP:0005116) | 6.01867866 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.71758045 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.71758045 |
6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.71758045 |
7 | Vascular tortuosity (HP:0004948) | 5.38262753 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.83953832 |
9 | Retinal atrophy (HP:0001105) | 4.73518574 |
10 | Polyphagia (HP:0002591) | 4.73212542 |
11 | Increased cerebral lipofuscin (HP:0011813) | 4.56359015 |
12 | Agitation (HP:0000713) | 4.42909051 |
13 | Complement deficiency (HP:0004431) | 4.36222256 |
14 | Cerebral aneurysm (HP:0004944) | 4.33329531 |
15 | Aortic aneurysm (HP:0004942) | 4.09010979 |
16 | Dysostosis multiplex (HP:0000943) | 3.88106545 |
17 | Gait imbalance (HP:0002141) | 3.81152250 |
18 | Myokymia (HP:0002411) | 3.78314245 |
19 | Nephronophthisis (HP:0000090) | 3.73935692 |
20 | Medial flaring of the eyebrow (HP:0010747) | 3.72681049 |
21 | Polygenic inheritance (HP:0010982) | 3.63942785 |
22 | Spondylolisthesis (HP:0003302) | 3.60260407 |
23 | Mutism (HP:0002300) | 3.50603723 |
24 | Amelogenesis imperfecta (HP:0000705) | 3.50106609 |
25 | Progressive neurologic deterioration (HP:0002344) | 3.44029597 |
26 | Chronic diarrhea (HP:0002028) | 3.34884160 |
27 | Urethral obstruction (HP:0000796) | 3.33751904 |
28 | Vacuolated lymphocytes (HP:0001922) | 3.31067741 |
29 | Aortic dissection (HP:0002647) | 3.29188613 |
30 | Progressive cerebellar ataxia (HP:0002073) | 3.28364794 |
31 | Nephrogenic diabetes insipidus (HP:0009806) | 3.26216434 |
32 | Congenital primary aphakia (HP:0007707) | 3.25685882 |
33 | Abnormality of complement system (HP:0005339) | 3.25014623 |
34 | Onycholysis (HP:0001806) | 3.23540628 |
35 | Partial duplication of thumb phalanx (HP:0009944) | 3.20758423 |
36 | Split foot (HP:0001839) | 3.19613832 |
37 | Recurrent abscess formation (HP:0002722) | 3.14387617 |
38 | Recurrent bacterial skin infections (HP:0005406) | 3.11760344 |
39 | Abnormality of midbrain morphology (HP:0002418) | 3.10883469 |
40 | Molar tooth sign on MRI (HP:0002419) | 3.10883469 |
41 | Orthostatic hypotension (HP:0001278) | 2.98126117 |
42 | Anomalous pulmonary venous return (HP:0010772) | 2.95443072 |
43 | True hermaphroditism (HP:0010459) | 2.93951535 |
44 | Striae distensae (HP:0001065) | 2.93620154 |
45 | Hematochezia (HP:0002573) | 2.91967082 |
46 | Vaginal atresia (HP:0000148) | 2.91738355 |
47 | Abnormality of the renal medulla (HP:0100957) | 2.88329254 |
48 | Limb dystonia (HP:0002451) | 2.86875805 |
49 | Pachygyria (HP:0001302) | 2.85901616 |
50 | Genital tract atresia (HP:0001827) | 2.85083041 |
51 | Nephritis (HP:0000123) | 2.83791757 |
52 | Partial duplication of the phalanx of hand (HP:0009999) | 2.77296545 |
53 | Lissencephaly (HP:0001339) | 2.76743745 |
54 | Mucopolysacchariduria (HP:0008155) | 2.74481919 |
55 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74481919 |
56 | Pancreatic fibrosis (HP:0100732) | 2.74170375 |
57 | Parakeratosis (HP:0001036) | 2.73218346 |
58 | Abnormal eating behavior (HP:0100738) | 2.68881847 |
59 | Cortical dysplasia (HP:0002539) | 2.68852369 |
60 | Amyloidosis (HP:0011034) | 2.66421512 |
61 | Hepatoblastoma (HP:0002884) | 2.65888277 |
62 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.65196797 |
63 | Abnormal pancreas size (HP:0012094) | 2.62073222 |
64 | Agnosia (HP:0010524) | 2.61950021 |
65 | Hepatosplenomegaly (HP:0001433) | 2.61867477 |
66 | Abnormality of the pulmonary veins (HP:0011718) | 2.60847424 |
67 | Disproportionate tall stature (HP:0001519) | 2.59578881 |
68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55937486 |
69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55937486 |
70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55937486 |
71 | Drooling (HP:0002307) | 2.55270436 |
72 | Intestinal atresia (HP:0011100) | 2.55112350 |
73 | Asplenia (HP:0001746) | 2.50862392 |
74 | Specific learning disability (HP:0001328) | 2.43595256 |
75 | Lip pit (HP:0100267) | 2.40697702 |
76 | Pancreatic cysts (HP:0001737) | 2.39911987 |
77 | Focal seizures (HP:0007359) | 2.39328498 |
78 | Excessive salivation (HP:0003781) | 2.39171536 |
79 | Abnormality of the corticospinal tract (HP:0002492) | 2.37626664 |
80 | Inappropriate behavior (HP:0000719) | 2.35987774 |
81 | Spastic tetraplegia (HP:0002510) | 2.34077045 |
82 | Hyperventilation (HP:0002883) | 2.33997476 |
83 | Poor coordination (HP:0002370) | 2.33567445 |
84 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.32799824 |
85 | Chronic hepatic failure (HP:0100626) | 2.31770631 |
86 | Multifactorial inheritance (HP:0001426) | 2.30657992 |
87 | Disinhibition (HP:0000734) | 2.29201748 |
88 | Hip dysplasia (HP:0001385) | 2.28432593 |
89 | Rib fusion (HP:0000902) | 2.28308436 |
90 | Adrenal hypoplasia (HP:0000835) | 2.25650043 |
91 | Anencephaly (HP:0002323) | 2.25605104 |
92 | Hypohidrosis (HP:0000966) | 2.23165265 |
93 | Pathologic fracture (HP:0002756) | 2.22576530 |
94 | Neoplasm of the adrenal cortex (HP:0100641) | 2.21914646 |
95 | Abnormality of the labia minora (HP:0012880) | 2.21043782 |
96 | Soft skin (HP:0000977) | 2.20361611 |
97 | Absent speech (HP:0001344) | 2.18874912 |
98 | Myositis (HP:0100614) | 2.17011768 |
99 | Epileptic encephalopathy (HP:0200134) | 2.16092804 |
100 | Broad-based gait (HP:0002136) | 2.16092364 |
101 | Abnormal platelet function (HP:0011869) | 2.13905665 |
102 | Impaired platelet aggregation (HP:0003540) | 2.13905665 |
103 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11972094 |
104 | Cardiomegaly (HP:0001640) | 2.11846748 |
105 | Eczematoid dermatitis (HP:0000976) | 2.11572050 |
106 | Abnormality of the aortic arch (HP:0012303) | 2.11316532 |
107 | Failure to thrive in infancy (HP:0001531) | 2.11242625 |
108 | Retinal dysplasia (HP:0007973) | 2.10409735 |
109 | Genetic anticipation (HP:0003743) | 2.09248474 |
110 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.07936818 |
111 | Hemiparesis (HP:0001269) | 2.07262694 |
112 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.07192700 |
113 | Hypoplasia of the brainstem (HP:0002365) | 2.07192700 |
114 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06983842 |
115 | Basal ganglia calcification (HP:0002135) | 2.06765128 |
116 | Joint stiffness (HP:0001387) | 2.06676367 |
117 | Peripheral hypomyelination (HP:0007182) | 2.06668135 |
118 | Erythema (HP:0010783) | 2.06341076 |
119 | Shawl scrotum (HP:0000049) | 2.05021168 |
120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03650126 |
121 | Septo-optic dysplasia (HP:0100842) | 2.02879710 |
122 | Sleep apnea (HP:0010535) | 2.01029591 |
123 | Retinitis pigmentosa (HP:0000510) | 2.00145496 |
124 | Restlessness (HP:0000711) | 1.99227011 |
125 | Arnold-Chiari malformation (HP:0002308) | 1.98963613 |
126 | Cheilitis (HP:0100825) | 1.97635419 |
127 | Chorioretinal atrophy (HP:0000533) | 1.97266764 |
128 | Abolished electroretinogram (ERG) (HP:0000550) | 1.96622197 |
129 | Premature loss of primary teeth (HP:0006323) | 1.96391560 |
130 | Thrombocytosis (HP:0001894) | 1.96142952 |
131 | Abnormality of the fovea (HP:0000493) | 1.95019643 |
132 | Growth hormone deficiency (HP:0000824) | 1.94525658 |
133 | J-shaped sella turcica (HP:0002680) | 1.93150585 |
134 | Amblyopia (HP:0000646) | 1.92293902 |
135 | Progressive visual loss (HP:0000529) | 1.91757205 |
136 | Thickened calvaria (HP:0002684) | 1.91101194 |
137 | Hypoplasia of the corpus callosum (HP:0002079) | 1.90604126 |
138 | Narrow forehead (HP:0000341) | 1.90417615 |
139 | Intellectual disability, severe (HP:0010864) | 1.90322895 |
140 | Short middle phalanx of the 5th finger (HP:0004220) | 1.88761402 |
141 | Short foot (HP:0001773) | 1.87348223 |
142 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87263933 |
143 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.87036282 |
144 | Short 4th metacarpal (HP:0010044) | 1.86304773 |
145 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.86304773 |
146 | Postaxial hand polydactyly (HP:0001162) | 1.84556889 |
147 | Diastasis recti (HP:0001540) | 1.84302019 |
148 | Premature skin wrinkling (HP:0100678) | 1.83794717 |
149 | Fetal akinesia sequence (HP:0001989) | 1.83000743 |
150 | Macular degeneration (HP:0000608) | 1.82799121 |
151 | Type II lissencephaly (HP:0007260) | 1.82798449 |
152 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81804715 |
153 | Slow-growing hair (HP:0002217) | 1.81694921 |
154 | Abnormality of hair growth rate (HP:0011363) | 1.81694921 |
155 | Congenital stationary night blindness (HP:0007642) | 1.81380755 |
156 | Bifid uvula (HP:0000193) | 1.81366992 |
157 | Plantar hyperkeratosis (HP:0007556) | 1.81298128 |
158 | Sclerocornea (HP:0000647) | 1.81012508 |
159 | Polymicrogyria (HP:0002126) | 1.79949152 |
160 | Pendular nystagmus (HP:0012043) | 1.78867062 |
161 | 3-Methylglutaconic aciduria (HP:0003535) | 1.78448961 |
162 | Dementia (HP:0000726) | 1.74969640 |
163 | Arterial thrombosis (HP:0004420) | 1.74786950 |
164 | Esotropia (HP:0000565) | 1.74462056 |
165 | Megalencephaly (HP:0001355) | 1.72892061 |
166 | Neurofibrillary tangles (HP:0002185) | 1.72612207 |
167 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.72309177 |
168 | Action tremor (HP:0002345) | 1.72179334 |
169 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.72019096 |
170 | Bicuspid aortic valve (HP:0001647) | 1.71754722 |
171 | Abnormal drinking behavior (HP:0030082) | 1.71471166 |
172 | Polydipsia (HP:0001959) | 1.71471166 |
173 | IgM deficiency (HP:0002850) | 1.70775899 |
174 | Broad face (HP:0000283) | 1.70078499 |
175 | Exotropia (HP:0000577) | 1.69623768 |
176 | Mitral valve prolapse (HP:0001634) | 1.69369753 |
177 | Renal dysplasia (HP:0000110) | 1.69120983 |
178 | Craniofacial hyperostosis (HP:0004493) | 1.67971694 |
179 | Aplasia involving bones of the extremities (HP:0009825) | 1.67442116 |
180 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.67442116 |
181 | Aplasia of the phalanges of the hand (HP:0009802) | 1.67442116 |
182 | Recurrent skin infections (HP:0001581) | 1.66060566 |
183 | Sparse eyelashes (HP:0000653) | 1.65090957 |
184 | Macroglossia (HP:0000158) | 1.64770866 |
185 | Neuronal loss in central nervous system (HP:0002529) | 1.64034337 |
186 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.61006135 |
187 | Erectile abnormalities (HP:0100639) | 1.60657755 |
188 | Atrophic scars (HP:0001075) | 1.59931101 |
189 | Ectropion (HP:0000656) | 1.57927156 |
190 | Mixed hearing impairment (HP:0000410) | 1.56785656 |
191 | Colitis (HP:0002583) | 1.56743860 |
192 | Axonal loss (HP:0003447) | 1.56568280 |
193 | Intestinal fistula (HP:0100819) | 1.54581551 |
194 | Cranial hyperostosis (HP:0004437) | 1.53854364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 8.70393813 |
2 | MARK1 | 4.62206182 |
3 | MAPK15 | 4.51756583 |
4 | GRK7 | 4.43158240 |
5 | CSF1R | 3.14340397 |
6 | EPHB2 | 2.74745883 |
7 | TSSK6 | 2.72886445 |
8 | DYRK2 | 2.71631318 |
9 | MAP2K7 | 2.53898861 |
10 | MAP3K4 | 2.29064944 |
11 | VRK1 | 2.28809445 |
12 | WNK3 | 2.16693524 |
13 | WNK4 | 2.08867417 |
14 | TYK2 | 1.84984389 |
15 | STK16 | 1.84062757 |
16 | MAPK12 | 1.83899037 |
17 | STK10 | 1.77155069 |
18 | MAP4K2 | 1.69618756 |
19 | PINK1 | 1.65315330 |
20 | PAK4 | 1.64468986 |
21 | TYRO3 | 1.61755557 |
22 | KIT | 1.61158172 |
23 | CLK1 | 1.60229808 |
24 | IRAK4 | 1.59529524 |
25 | CDK3 | 1.58258708 |
26 | CSNK1G2 | 1.51394669 |
27 | PDK2 | 1.49968707 |
28 | EEF2K | 1.44539565 |
29 | DYRK3 | 1.44035640 |
30 | IRAK3 | 1.43695026 |
31 | YES1 | 1.39676731 |
32 | DYRK1B | 1.37290302 |
33 | MAPKAPK3 | 1.37245835 |
34 | PRKCG | 1.35631242 |
35 | NTRK3 | 1.34971996 |
36 | CAMK1D | 1.34753127 |
37 | CDK19 | 1.33674950 |
38 | MINK1 | 1.33174945 |
39 | MAP2K4 | 1.32562427 |
40 | SGK494 | 1.30522545 |
41 | SGK223 | 1.30522545 |
42 | CDK8 | 1.30164491 |
43 | ADRBK2 | 1.29853926 |
44 | MARK2 | 1.27733593 |
45 | PAK3 | 1.26451342 |
46 | ERBB3 | 1.24217286 |
47 | BCR | 1.24085573 |
48 | EPHA3 | 1.23726028 |
49 | MAPK7 | 1.15774582 |
50 | RIPK4 | 1.14983556 |
51 | MOS | 1.11769141 |
52 | CSNK1G3 | 1.11474871 |
53 | CSNK1A1L | 1.10822134 |
54 | EPHA4 | 1.10266040 |
55 | CAMKK1 | 1.08333842 |
56 | BTK | 1.07989189 |
57 | BMPR1B | 1.07224665 |
58 | ZAK | 1.06774305 |
59 | ITK | 1.02866793 |
60 | TNIK | 0.99418779 |
61 | PIM2 | 0.98961869 |
62 | LYN | 0.98029240 |
63 | TRPM7 | 0.97780312 |
64 | MAPKAPK5 | 0.97073900 |
65 | TAOK3 | 0.95867545 |
66 | HCK | 0.94616460 |
67 | GRK1 | 0.93568109 |
68 | TEC | 0.92558905 |
69 | JAK1 | 0.90591502 |
70 | MAP3K3 | 0.89841766 |
71 | DYRK1A | 0.88609453 |
72 | FLT3 | 0.87440030 |
73 | ZAP70 | 0.86715419 |
74 | BLK | 0.86094771 |
75 | TXK | 0.85252109 |
76 | TNK2 | 0.84873458 |
77 | MAP4K1 | 0.84727969 |
78 | TGFBR1 | 0.83873987 |
79 | PIK3CG | 0.82969701 |
80 | SIK3 | 0.82093877 |
81 | CDK5 | 0.82070391 |
82 | CSNK1G1 | 0.81855515 |
83 | PTK6 | 0.81473277 |
84 | CAMK1G | 0.80874720 |
85 | SYK | 0.79558570 |
86 | BCKDK | 0.79548864 |
87 | TBK1 | 0.78619340 |
88 | PNCK | 0.78037318 |
89 | MAP3K11 | 0.78020353 |
90 | EIF2AK2 | 0.77920510 |
91 | PKN1 | 0.77513927 |
92 | STK39 | 0.76402449 |
93 | MAP2K3 | 0.74798363 |
94 | INSRR | 0.74494484 |
95 | SGK2 | 0.73845987 |
96 | LIMK1 | 0.73755921 |
97 | JAK2 | 0.71792444 |
98 | PRKCZ | 0.71126109 |
99 | IGF1R | 0.69951464 |
100 | FES | 0.69638761 |
101 | PRKCH | 0.69257601 |
102 | LCK | 0.68595986 |
103 | CAMKK2 | 0.67756946 |
104 | GRK5 | 0.66937885 |
105 | MAP3K14 | 0.66871846 |
106 | ERN1 | 0.64259494 |
107 | PAK6 | 0.62266473 |
108 | STK24 | 0.62001941 |
109 | RPS6KA2 | 0.61979025 |
110 | STK11 | 0.61868806 |
111 | MATK | 0.60008366 |
112 | MAPKAPK2 | 0.59163947 |
113 | MAPK13 | 0.58955303 |
114 | MKNK2 | 0.55334547 |
115 | MAPK4 | 0.55193347 |
116 | PKN2 | 0.54166835 |
117 | CAMK4 | 0.54108043 |
118 | MKNK1 | 0.53796976 |
119 | MAP3K9 | 0.53321644 |
120 | UHMK1 | 0.53218998 |
121 | PRKCE | 0.51663637 |
122 | PAK2 | 0.51342893 |
123 | PRKACA | 0.51151123 |
124 | MAP3K6 | 0.50163197 |
125 | RPS6KA6 | 0.49903870 |
126 | CCNB1 | 0.49262210 |
127 | FGFR2 | 0.49074018 |
128 | DAPK2 | 0.46247823 |
129 | KSR1 | 0.45974735 |
130 | BRAF | 0.45919162 |
131 | RPS6KB2 | 0.45743132 |
132 | PRKD3 | 0.44111229 |
133 | FRK | 0.43269234 |
134 | MAP2K6 | 0.43031662 |
135 | SIK2 | 0.42792892 |
136 | SIK1 | 0.41421213 |
137 | ICK | 0.41026044 |
138 | CAMK2A | 0.40666337 |
139 | CDK14 | 0.39986008 |
140 | CASK | 0.39588056 |
141 | PRKCQ | 0.38506192 |
142 | PHKG2 | 0.37679798 |
143 | PHKG1 | 0.37679798 |
144 | SGK3 | 0.37655619 |
145 | IKBKB | 0.37151766 |
146 | NTRK2 | 0.36819383 |
147 | RPS6KL1 | 0.36393263 |
148 | RPS6KC1 | 0.36393263 |
149 | CAMK1 | 0.36296957 |
150 | ADRBK1 | 0.36198007 |
151 | PLK3 | 0.34795776 |
152 | LMTK2 | 0.34700924 |
153 | PRKD2 | 0.34578835 |
154 | SGK1 | 0.34535854 |
155 | ABL2 | 0.34312357 |
156 | DDR2 | 0.33280466 |
157 | FGFR3 | 0.33011818 |
158 | DMPK | 0.32132713 |
159 | ERBB2 | 0.32128278 |
160 | PRKG1 | 0.31964815 |
161 | CDK6 | 0.31404297 |
162 | JAK3 | 0.31154249 |
163 | ACVR1B | 0.30099074 |
164 | MARK3 | 0.29305720 |
165 | CSK | 0.28923113 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.88484360 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.46423616 |
3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.12282026 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.63847887 |
5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.44322000 |
6 | Nicotine addiction_Homo sapiens_hsa05033 | 3.23347790 |
7 | Phototransduction_Homo sapiens_hsa04744 | 2.76085168 |
8 | Lysosome_Homo sapiens_hsa04142 | 2.58887474 |
9 | Morphine addiction_Homo sapiens_hsa05032 | 2.56320649 |
10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.46690308 |
11 | Axon guidance_Homo sapiens_hsa04360 | 2.33481901 |
12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.30934657 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29085036 |
14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16458732 |
15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.15065505 |
16 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.14775407 |
17 | GABAergic synapse_Homo sapiens_hsa04727 | 2.14230718 |
18 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.08746231 |
19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07501746 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98934767 |
21 | Pertussis_Homo sapiens_hsa05133 | 1.98665341 |
22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96891538 |
23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95315948 |
24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.83959977 |
25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.83713645 |
26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.82966302 |
27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.78606293 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76963568 |
29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.76227559 |
30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68190051 |
31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65154314 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.62055042 |
33 | Prion diseases_Homo sapiens_hsa05020 | 1.54206449 |
34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51326034 |
35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.50105452 |
36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47955520 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46267660 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43877661 |
39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42455036 |
40 | Legionellosis_Homo sapiens_hsa05134 | 1.37420930 |
41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.37266329 |
42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34513749 |
43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.33255442 |
44 | Insulin secretion_Homo sapiens_hsa04911 | 1.31345875 |
45 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.31128043 |
46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29290905 |
47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.27284182 |
48 | Colorectal cancer_Homo sapiens_hsa05210 | 1.26775792 |
49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26060820 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24140332 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20476406 |
52 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.18955877 |
53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15948011 |
54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15883235 |
55 | Tuberculosis_Homo sapiens_hsa05152 | 1.14725475 |
56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.13926361 |
57 | Long-term depression_Homo sapiens_hsa04730 | 1.12668373 |
58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10750991 |
59 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08453977 |
60 | Malaria_Homo sapiens_hsa05144 | 1.04427156 |
61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04131262 |
62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01343473 |
63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.00987437 |
64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00371356 |
65 | Influenza A_Homo sapiens_hsa05164 | 0.99359694 |
66 | Platelet activation_Homo sapiens_hsa04611 | 0.98745838 |
67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97419673 |
68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96622200 |
69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95414741 |
70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.95107189 |
71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93126361 |
72 | Hepatitis B_Homo sapiens_hsa05161 | 0.92609765 |
73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90993820 |
74 | Salmonella infection_Homo sapiens_hsa05132 | 0.89513362 |
75 | Taste transduction_Homo sapiens_hsa04742 | 0.86955322 |
76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.86940411 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86622374 |
78 | Gap junction_Homo sapiens_hsa04540 | 0.86366829 |
79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84714794 |
80 | Measles_Homo sapiens_hsa05162 | 0.83677725 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82778994 |
82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80998825 |
83 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78457227 |
84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.78058306 |
85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77541256 |
86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76590184 |
87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76005410 |
88 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75894209 |
89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75261700 |
90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73978512 |
91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72808789 |
92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70419135 |
93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70229269 |
94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69112572 |
95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68990305 |
96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68188932 |
97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66818130 |
98 | Endocytosis_Homo sapiens_hsa04144 | 0.66205677 |
99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65863002 |
100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65811888 |
101 | Adherens junction_Homo sapiens_hsa04520 | 0.65040525 |
102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64271730 |
103 | Phagosome_Homo sapiens_hsa04145 | 0.63500545 |
104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63441000 |
105 | Melanogenesis_Homo sapiens_hsa04916 | 0.61358088 |
106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61172127 |
107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59853722 |
108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58859038 |
109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58835567 |
110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58473403 |
111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58325159 |
112 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58272298 |
113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58165703 |
114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57364965 |
115 | Apoptosis_Homo sapiens_hsa04210 | 0.56598015 |
116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56432217 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.56110545 |
118 | Melanoma_Homo sapiens_hsa05218 | 0.55450723 |
119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.53115361 |
120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53094584 |
121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51389496 |
122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49811164 |
123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49548246 |
124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48922005 |
125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48516369 |
126 | Protein export_Homo sapiens_hsa03060 | 0.47929446 |
127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47596093 |
128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47123273 |
129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45451275 |
130 | Shigellosis_Homo sapiens_hsa05131 | 0.44776863 |
131 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42833150 |
132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41564445 |
133 | Salivary secretion_Homo sapiens_hsa04970 | 0.41321259 |
134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40727161 |
135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40246573 |
136 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38686621 |
137 | Renin secretion_Homo sapiens_hsa04924 | 0.37990631 |
138 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36931580 |
139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36317662 |
140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35482748 |
141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34757081 |
142 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33651911 |
143 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33582290 |
144 | Peroxisome_Homo sapiens_hsa04146 | 0.33320878 |
145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33235758 |
146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32610783 |
147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32473049 |
148 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31512825 |
149 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31162480 |
150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30474963 |
151 | Amoebiasis_Homo sapiens_hsa05146 | 0.29433794 |
152 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29415908 |
153 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29356199 |
154 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29337989 |
155 | Glioma_Homo sapiens_hsa05214 | 0.28980642 |
156 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27011742 |
157 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24482943 |
158 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23966853 |
159 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.23488668 |
160 | Hepatitis C_Homo sapiens_hsa05160 | 0.23195282 |
161 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22473913 |